Episodios

  • Rethinking DX: A Digital DSM and the Roots of Mental Health

    Rethinking DX: A Digital DSM and the Roots of Mental Health
    Mar 31 2026

    "Rethinking DX: A Digital DSM" looks at how the Diagnostic and Statistical Manual of Mental Disorders (DSM) quietly shapes almost every part of mental health care—from who gets a diagnosis and insurance coverage to how people understand their own symptoms and identities. In this conversation, Lita and Jean Marie unpack what the DSM actually is, why the current DSM‑5‑TR matters, and how a future, fully digital "DSM‑6" could function as a living document that updates more quickly, links to decision‑support tools, and better integrates real‑world data from electronic health records.​

    They explore the growing push to move beyond symptom checklists and include factors like biology and inflammation, social determinants (poverty, racism, housing instability, community violence), culture and language, life stage, trauma history, and even nutrition and the gut–brain connection when understanding mental health. The episode also imagines what a visit with a clinician using a digital DSM might look like—from plain‑language criteria and prompts about trauma and physical health, to culturally sensitive questions and age‑specific guidance—while encouraging listeners to bring their whole story to appointments, ask how environment and biology interact in their own case, and get involved in shaping future DSM updates through advocacy and lived‑experience input.​
    Más Menos
    21 m
  • The Next Decade in Medicine

    The Next Decade in Medicine
    Mar 24 2026

    Over the next decade, medicine won't just add new gadgets—it will change what it feels like to be a patient. In this episode of PodcastDX, we explore how AI as a clinical co‑pilot, stem cells and regenerative medicine, genomics and precision care, wearables, and hospital‑at‑home models could reshape everyday care. We talk about the promise of earlier detection and more personalized treatment, the risks around bias, privacy, and hype, and why equity and shared decision‑making must stay at the center as technology races ahead. Most of all, we ask how patients and caregivers can be partners—not passengers—in guiding the future of medicine.
    Más Menos
    21 m
  • Patients as Partners: Shared Decision Making in Medicine

    Patients as Partners: Shared Decision Making in Medicine
    Mar 17 2026

    This week we are discussing the rise of a new type of health care where the patients play a vital role in their medical care. Patients as partners in care are at the heart of shared decision making (SDM), a model where clinicians and patients deliberately work together to choose tests and treatments that fit both best evidence and the patient's values and life context.

    What shared decision making means

    • SDM is a collaborative process in which clinicians contribute clinical expertise while patients contribute their goals, preferences, and lived experience.

    • Core elements include at least two participants (patient and clinician), information sharing in both directions, building a shared understanding of options, and aiming for agreement on what to do next.

    From paternalism to partnership

    • Historically, medical care was strongly paternalistic, with clinicians deciding and patients expected to comply, but from the 1970s onward, growing emphasis on autonomy and patient‑centered care began to challenge this model.

    • The term "shared decision-making" appeared in ethical discussions in the 1970s and early 1980s and gained momentum in the 1980s alongside evidence that patients increasingly wanted to participate in decisions.

    Why patients as partners matters

    • SDM is associated with improved patient knowledge, more accurate risk perception, reduced decisional conflict, and treatment plans that better reflect what matters most to patients.

    • Studies link SDM to higher satisfaction, better adherence, improved quality of life, lower anxiety, and in some preference‑sensitive conditions, less invasive and sometimes less costly care.
    Más Menos
    20 m
  • End of Life in Transition: Earlier Palliative Care, Better Conversations

    End of Life in Transition: Earlier Palliative Care, Better Conversations
    Mar 10 2026
    At a time when modern medicine is allowing people to enjoy longer, fuller lives, mortality is not always a chief concern. But when a serious illness occurs, the topic becomes unavoidable. This became especially clear during the early days of the COVID-19 pandemic when hospitals were overrun with patients, many with grim prognoses. "The pandemic gave all of us a sense that life can be short and there's the very real possibility of dying," says Jennifer Kapo, MD, director of the Palliative Care Program at Yale New Haven Hospital. "It opened the door for us to talk more about death and have a better sense of our mortality." Palliative care is a caregiving approach for anyone with a serious or chronic medical condition; its goal is to maximize quality of life and manage symptoms. In addition to helping patients and their families navigate difficult conversations and decisions, palliative care team members are attentive to "goals of care," which means understanding the patient's wishes and how medical steps can help achieve them. For example, if a patient has a low likelihood of coming off a ventilator, that would be made clear to them, if possible, before they were put on one, explains Laura Morrison, MD, a physician in the Palliative Care Program. "The pandemic highlighted the need for us to have more proactive and earlier conversations with patients and their families. If we gave them the chance to make a choice, some might say they don't want to die in an intensive care unit," Dr. Kapo adds. Still, many people still aren't sure what palliative care really means. Below, we talk with a few members of Yale Medicine's program to better understand it. How does palliative care differ from hospice care? Palliative care is a specialized model of care for people living with serious or chronic illnesses including cancer, heart and liver failure, dementia, and pulmonary disease. Like hospice care, the focus is on maximizing comfort and quality of life. But palliative and hospice care differ in that hospice is for patients who are not receiving life-extending treatment, and is typically limited to the last six months—or less—of one's life. Palliative care, conversely, can be integrated into a patient's medical care at any point during their illness, from diagnosis to end-of-life, and can include life-extending medical treatment. "Essentially, palliative care is an extra layer of support for any patient who has a serious illness. That can include attention to pain and other symptom management, as well as help coping with the stress of having the illness," Dr. Morrison explains. "We also focus on facilitating communication between patients, their families, and medical providers." The Palliative Care Program has 35 members in various disciplines, including physicians, nurses, social workers, a chaplain, a psychologist, and a pharmacist. Palliative care services are offered to all patients at Yale New Haven Hospital and Smilow Cancer Hospital, and at Smilow's outpatient offices. And it provides care on a spectrum, based on what patients and their loved ones need in the moment. "At the beginning of a serious illness, a patient's needs might revolve around addressing anxiety over their diagnosis," Dr. Kapo says. Plus, taking care of the entire family, and not just the patient, is an important element, Dr. Kapo adds. "Our goal is to provide the best quality of life possible to patients and their families, which is why our bereavement program is also an important element. Our care does not stop when a loved one dies," she says. How is palliative care broached with patients? Because Yale Medicine offers palliative care to hospitalized patients, that is often where someone first hears about the model of care. "We typically structure the conversation broadly at first and ask a patient what they understand about their illness, what they have heard about it, and what they believe about it," Dr. Kapo says. "If a patient has no idea that death is a real possibility, we spend a lot of time sharing information. Or, if they have been sick for five years and know that time may be short, we talk about what is important to them and what they want to do with the time they have left." That, Dr. Kapo says, opens a conversation about a patient's values. "We listen very carefully and get a sense of whether this is a patient with goals of wanting to extend life no matter what it takes, or someone who is more interested in quality of life," she says. The goal of palliative care is not to change a patient's mind about their decisions, she adds. "It's to listen to a patient's story and support their decisions," Dr. Kapo says. "If someone tells me that they will fight for every last second of life, no matter what the cost might be physically, then we honor that." Meanwhile, a social worker can provide support and address any psychosocial issues. For example, if someone is just diagnosed with a critical illness, their primary ...
    Más Menos
    10 m
  • Is Mental Health Care Changing Fast Enough

    Is Mental Health Care Changing Fast Enough
    Mar 3 2026
    This week we discuss the current status of Mental Health Care. Mental health care is changing, but most experts argue it is not changing fast enough relative to the need, especially on access, equity, and workforce. Where change is too slow Unmet need is huge. In the U.S., millions with a diagnosable condition still receive no treatment each year; a recent national report notes that many adults with mental illness remain uninsured or unable to access care.​ Global workforce shortages. Nearly 50% of the world's population lives in countries with fewer than 1 psychiatrist per 100,000 people, which severely limits access.​ Specialist shortages in high‑income countries. Projections for the U.S. estimate a shortage of roughly 14,000–31,000 psychiatrists, with over half of counties having none at all, and this gap may persist for decades without major policy changes. System design still hospital‑centered. The WHO notes that two‑thirds of scarce mental health budgets still go to stand‑alone psychiatric hospitals rather than community‑based services, despite all countries having signed on to a reform plan.​ Persistent inequities. Underserved groups (rural communities, people of color, LGBTQ+ people, low‑income populations) face additional barriers like providers not taking Medicaid/Medicare, language gaps, and local provider deserts.​ What is changing quickly Telehealth and virtual care. Teletherapy and virtual mental health visits expanded dramatically and now make it easier to reach people regardless of location, with greater scheduling flexibility and fewer logistical barriers. Digital mental health tools. Apps and web programs delivering structured therapies (for example CBT modules) can reduce symptoms of depression and anxiety with moderate to high effect sizes, including in low‑resource settings. New care pathways. Systems are experimenting with brief interventions, stepped‑care models, peer‑support programs, and task‑sharing where general health workers and community providers deliver basic mental health support. Policy and parity efforts. Some U.S. states are strengthening mental health parity enforcement, improving network adequacy, and changing insurance rules to make psychiatric medications and services easier to access.​ Stigma is slowly decreasing. Recent commentary highlights that more people are willing to seek help, pushing demand higher and driving interest in more personalized, data‑driven psychiatric care.​ Big picture: mismatch between need and pace Demand is outpacing innovation. Trauma, pandemic aftereffects, economic stress, and social unrest have increased mental health needs faster than systems can expand the workforce or redesign care, deepening inequities. Technology helps but isn't a cure‑all. Digital tools and telehealth extend reach, but quality is uneven, many apps lack strong evidence, and people with the most severe conditions still need intensive, in‑person, multidisciplinary care. Global agencies explicitly say pace is inadequate. The WHO's own assessment is that "change is not happening fast enough," framing the current situation as one of ongoing need and neglect despite clear evidence of what would work better.​ What would "fast enough" look like? Large‑scale investment in community‑based services and integration of mental health into primary care, shifting funding away from institutional‑only models.​ Aggressive strategies to grow and sustain the mental health workforce (training, better reimbursement, support to prevent burnout, incentives for underserved areas). Wider, evidence‑based use of digital interventions and telehealth, with standards for safety, privacy, and effectiveness so people can trust what they are using. Stronger parity enforcement and policies that make it actually practical—not just theoretically covered—to find and afford care. If you think about your own community or the people you work with, do you feel the main barrier is access (finding/affording care), quality (getting the right care), or something else like stigma or navigation?
    Más Menos
    33 m
  • Rehabilitation Reimagined: Technology, Therapy and Independence

    Rehabilitation Reimagined: Technology, Therapy and Independence
    Feb 24 2026
    The integration of Artificial Intelligence (AI) into post-injury rehabilitation is transforming recovery paradigms by enabling personalized, adaptive, and efficient rehabilitation pathways tailored to individual patient needs. This podcast reviews the current advances in AI applications that facilitate assessment, monitoring, and optimization of rehabilitation programs following injuries. Through machine learning algorithms, wearable sensors, and predictive analytics, AI enhances the precision of therapy plans, tracks patient progress in real-time, and predicts recovery trajectories. The discussion includes the benefits of AI-driven rehabilitation, including improved functional outcomes, reduced recovery times, and increased patient engagement. It also addresses challenges such as data privacy, algorithmic bias, and integration with clinical workflows. 1. Transforming recovery paradigms Traditional post‑injury rehab relies on periodic in‑person assessments, therapist intuition, and standardized protocols that only partially account for individual variability. AI is shifting this model toward: Continuous, data‑driven care: Instead of snapshots in clinic, rehab can be informed by near real‑time streams of kinematic, physiological, and behavioral data from wearables, smart devices, and robot interfaces. Dynamic adaptation: Therapy intensity, task difficulty, and exercise selection can be automatically adjusted based on ongoing performance, fatigue, and recovery trends, rather than fixed schedules. Precision rehabilitation: Algorithms can identify which patients are likely to respond to specific interventions (e.g., constraint‑induced movement therapy vs robotics) and tailor plans accordingly. This moves rehabilitation from a "one‑size‑fits‑many" paradigm toward precision, context‑aware therapy, analogous to precision oncology but focused on function and participation. 2. Assessment, monitoring, and optimization AI for assessment Sensor‑based movement analysis: Machine learning models process accelerometer, IMU, EMG, and pressure data to quantify gait symmetry, joint kinematics, balance, and fine motor control with higher resolution than visual observation alone. Automated scoring: AI can approximate or support standardized scales (e.g., Fugl‑Meyer, Berg Balance Scale) by mapping sensor features or video-derived pose estimates to clinical scores, reducing inter‑rater variability and saving clinician time. Continuous monitoring Home and community tracking: Wearable and ambient sensors enable monitoring of daily steps, walking speed, arm use, posture, and adherence to exercises outside the clinic, feeding rich longitudinal datasets into AI models. Real‑time alerts: Algorithms can detect abnormal patterns—such as increased fall risk, reduced limb use, or signs of over‑exertion—and flag the clinician or adjust digital therapy content automatically. Optimization and decision support Predictive models: Using historical data, AI can forecast functional gains, plateau points, or risk of complications (e.g., falls, readmission), supporting individualized goal‑setting and resource allocation. Reinforcement learning and "digital twins": Emerging work in neurorehabilitation treats rehab as a sequential decision problem, using model‑based reinforcement learning and patient "digital twins" to recommend optimal timing, dosing, and progression of interventions over weeks to months.​ 3. Technologies: ML, wearables, analytics Machine learning algorithms: Supervised ML classifies movement quality (normal vs compensatory), detects exercise type from sensor streams, and estimates clinical scores. Unsupervised learning clusters patients into phenotypes (e.g., gait patterns after stroke), revealing subgroups that respond differently to certain therapies. Reinforcement learning and contextual bandits explore which therapy adjustments yield the best long‑term functional outcomes for a given individual.​ Wearable sensors and robotics: Inertial sensors, EMG, pressure insoles, and exoskeleton sensors capture high‑frequency movement and muscle activity data during training. Robotic devices (upper‑limb exoskeletons, gait trainers) coupled with AI can modulate assistance, resistance, or task difficulty in real time based on performance and predicted fatigue. Predictive and prescriptive analytics: Predictive analytics estimate trajectories (e.g., time to independent walking, expected upper‑limb function) to inform shared decisions with patients and families. Prescriptive analytics recommend therapy intensity, modality mix, and scheduling to maximize functional gains under resource constraints. 4. Benefits: outcomes, efficiency, engagement Improved functional outcomes: Studies report better motor recovery, gait quality, and ADL performance when AI‑assisted training is used—especially when robotics and intelligent ...
    Más Menos
    19 m
  • The Gut Brain Revolution

    The Gut Brain Revolution
    Feb 17 2026

    The gut–brain revolution is about treating the digestive system and the nervous system as one integrated network instead of two separate organs that happen to share a body. The gut–brain axis is a bidirectional communication system: the brain influences digestion, motility, and gut sensation, while the gut and its microbiota send chemical, neural, and immune signals back to the brain that can shape mood, cognition, and even neurodegeneration. Central to this loop is the vagus nerve, the longest cranial nerve, which carries most of the traffic from gut to brain and modulates inflammation, intestinal permeability, and autonomic balance. When one side of this axis is struggling—chronic stress, trauma, infection, dysbiosis, "leaky gut," or ongoing inflammation—the other side often shows up with symptoms like anxiety, depression, brain fog, or functional GI disorders.​

    Because of this, "treating the brain" without addressing gut health, or "treating the gut" without considering mental health and stress physiology, often means chasing symptoms instead of root causes. Emerging evidence supports combined care plans that may blend nutrition changes, targeted probiotics, and anti‑inflammatory strategies with cognitive behavioral therapy, mindfulness, and stress‑reduction techniques to calm both the GI tract and the nervous system. Interventions that support vagal tone—such as paced breathing, certain forms of meditation, and gentle movement—may further help regulate this axis by improving autonomic balance and reducing inflammatory signaling between gut and brain. For patients and clinicians, the key message is that persistent "brain" symptoms might start in the gut, and chronic "gut" symptoms may be maintained by the brain, making integrated, two‑system treatment not a trend but a clinical necessity.
    Más Menos
    22 m
  • Promising New Cancer Screening Methods

    Promising New Cancer Screening Methods
    Feb 10 2026
    Promising new cancer screening methods are pivoting toward multi-cancer early detection (MCED) blood tests (liquid biopsies) and AI-enhanced imaging, which aim to detect multiple cancer types from a single, non-invasive sample, often before symptoms arise. These technologies, including the Galleri test and Novelna's protein-based tests, analyze DNA, proteins, or methylation patterns to identify cancer signals.
    • Multi-Cancer Early Detection (MCED) Blood Tests: These tests, often called liquid biopsies, detect DNA or proteins shed by cancer cells into the bloodstream, identifying early-stage cancers (e.g., ovarian, pancreatic) that lack standard screening protocols.
      • Galleri Test: Analyzes chemical methylation patterns to detect over 50 types of cancer, with the potential to indicate the cancer's origin in the body.
      • Novelna's Test: An experimental test analyzing protein signatures, showing high accuracy in identifying 18 early-stage cancers, including 93% of stage 1 cancers in men.
      • TriOx Test: A new, Oxford-developed test showing high sensitivity in detecting trace cancer DNA.
    • AI and Machine Learning in Screening: AI is enhancing existing imaging techniques (e.g., mammography) to improve accuracy and efficiency in reading scans, reducing false positives.
    • Other Liquid Biopsies: Research into analyzing blood, breath, and urine for early signs of cancer, offering a less invasive alternative to tissue biopsies.
    While offering immense promise for reducing cancer mortality, many of these technologies, including MCED, are still in research or early implementation phases, and they can produce false positives.
    Más Menos
    20 m